FocusAutism

Tweaking the Social Network

See allHide authors and affiliations

Science Translational Medicine  25 Apr 2012:
Vol. 4, Issue 131, pp. 131fs9
DOI: 10.1126/scitranslmed.3004017

You are currently viewing the abstract.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Abstract

Paving the way for clinical trials, a new study shows that a glutamate receptor antagonist reduces repetitive behavior and social deficits in a mouse model of autism spectrum disorder.

View Full Text